Erratum (DOI:10.1016/j.urology.2008.07.042);Evidence-based Sex-related Outcomes After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: Results of Large Multicenter Study

Urology

Volumn 73, Issue 1, 2009, Pages 142-146

  Fernández, Mario I ^a   Shariat, Shahrokh F ^b   Margulis, Vitaly ^c   Bolenz, Christian ^d   Montorsi, Francesco ^e   Suardi, Nazareno ^f   Remzi, Mesut ^g   Wood, Christopher G ^c   Roscigno, Marco ^e   Kikuchi, Eiji ^h   Oya, Mototsugu ^h   Zigeuner, Richard ⁱ   Langner, Cord ⁱ   Weizer, Alon ^j   Lotan, Yair ^b   Koppie, Theresa M ^k   Raman, Jay D ^l   Karakiewizc, Pierre ^f   Bensalah, Karim ^m   Schultz, Marcela ^a   Bernier, Pablo ^a   more..

^a UNIVERSIDAD DEL DESARROLLO   (Chile)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

^g UNIVERSITY OF VIENNA   (Austria)

^h KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ MEDICAL UNIVERSITY OF GRAZ   (Austria)

^j UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l Department of Obstetrics Gynecology   (United States)

^m UNIVERSITÉ DE RENNES 1   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; CONTROLLED STUDY; EVIDENCE BASED PRACTICE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; PRIORITY JOURNAL; SEX DIFFERENCE; SEX RATIO; UROGENITAL TRACT CANCER;

EID: 57849113914     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.03.009     Document Type: Erratum

References (19)

1. Hall M.C., Womack S., Sagalowsky A.I., et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: A 30-year experience in 252 patients. Urology 52 (1998) 594-601
2. Novara G., De Marco V., Gottardo F., et al. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer 110 (2007) 1715-1722
3. Munoz J.J., and Ellison L.M. Upper tract urothelial neoplasms: Incidence and survival during the last 2 decades. J Urol 164 (2000) 1525-1532
4. Oosterlink W., Solsona E., van der Meijden A.P.M., et al. EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol 46 (2004) 147-154
5. Mungan N.A., Aben K.H.K., Schoenberg M.P., et al. Gender differences in stage-adjusted bladder cancer survival. Urology 55 (2000) 876-880
6. Puente D., Malats N., Cecchini L., et al., EPICURO Study Group Investigators. Gender related differences in clinical and pathological characteristics and therapy of bladder cancer. Eur Urol 43 (2003) 53-62
7. Mungan N.A., Kiemeney L.A.A.L., Van Dijck J.A.A.M., et al. Gender differences in stage distribution of bladder cancer. Urology 55 (2000) 368-371
8. Cheng H.L., Chow N.H., Tzai T.S., et al. Prognostic significance of proliferating cell nuclear antigen expression in transitional cell carcinoma of the upper urinary tract. Anticancer Res 17 suppl 4A (1997) 2789-2793
9. Koga F., Nagamatsu H., Ishimaru H., et al. Risk factors for the development of bladder transitional cell carcinoma following surgery for transitional cell carcinoma of the upper urinary tract. Urol Int 67 (2001) 135-141
10. Li C.C., Chang T.H., Wu W.J., et al. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol (2008) doi:10.1016/j.eururo.2008.01.054
11. Greene F.L., Page D.L., Fleming I.D., et al. AJCC Cancer Staging Manual. 6th ed. (2002), Springer Verlag, Philadelphia
12. Epstein J.I., Amin M.B., Reuter V.R., et al., Bladder Consensus Conference Committee. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 22 (1998) 1435-1448
13. Grambsch P.M., and Therneau T.M. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81 (1994) 515-526
14. Harrell Jr. F.E., Califf R.M., Pryor D.B., et al. Evaluating the yield of medical tests. JAMA 247 (1982) 2543-2546
15. Harrell Jr. F.E., Lee K.L., and Mark D.B. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15 (1996) 361-387
16. Micheli A., Mariotto A., Rossi A.G., et al., Eurocare Working Group. The prognostic role of gender in survival of adult cancer patients. Eur J Cancer 34 (1998) 2271-2278
17. Maralani S., Wood D.P., Grignon D., et al. Incidence of urethral involvement in female bladder cancer. Urology 50 (1997) 537-541
18. Krogh J., Kvist E., and Rye B. Transitional cell carcinoma of the upper urinary tract: Prognostic variables and post-operative recurrences. Br J Urol 67 (1991) 32-36
19. Das A.K., Culley C.C., Bolick D., et al. Primary carcinoma of the upper urinary tract: Effect of primary and secondary therapy on survival. Cancer 66 (1990) 1919-1923